Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Non-obese women with hair loss have higher heart disease risk.

Anagen effluvium is a reversible condition causing sudden hair loss, often due to chemotherapy or head radiation.

A 2-year-old boy with a rare type of lupus causing hair loss improved with oral steroids.

Shallot extract may help with hair growth and treating hair loss.

The document concludes that there are various treatments for diseases linked to scarring hair loss, especially for primary scarring alopecia.

Hair loss (telogen effluvium) cases rose during the pandemic, especially in Hispanic and non-White groups, and were linked to other health issues and COVID-19.

Trichoscopy shows black dots, yellow dots, and empty follicles are common in Alopecia Areata, with broken and exclamation mark hair as typical patterns.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Managing multiple autoimmune diseases in one patient is very challenging.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Practitioners treating hair loss need better education and resources to overcome challenges like commercial bias and ethical dilemmas.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Certain growth factors affect hair loss in women and could be targeted for treatment.

Temporary hair loss can happen after a facial rejuvenation procedure due to blood flow blockage caused by a certain filler.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Focal alopecia in dogs has many causes and requires various tests for accurate diagnosis and treatment.

Educating healthcare workers and parents about hair toe tourniquets can help prevent serious complications.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Non-ablative radio frequency can potentially increase hair count in men with androgenetic alopecia, but some may be bothered by the smell during treatment.

A 5-year-old boy was diagnosed with congenital triangular alopecia, a type of hair loss without skin changes, usually starting between ages 2-5, with no specific treatment.

The article suggests that hair transplant surgery may not be purely cosmetic because it treats a disease and calls for clearer guidelines on its classification.